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Abstract
Vitamin D has been linked with many health outcomes. The aim of this longitudinal study, was to assess predictors of
seasonal variation of 25-hydroxy-vitamin D (25(OH)D) (including use of supplements and holidays in sunny destinations) at
a northerly latitude in the UK (57uN) in relation to bone health indicators. 365 healthy postmenopausal women (mean age
62.0 y (SD 1.4)) had 25(OH)D measurements by immunoassay, serum C-telopeptide (CTX), estimates of sunlight exposure
(badges of polysulphone film), information regarding holidays in sunny destinations, and diet (from food diaries, including
use of supplements such as cod liver oil (CLO)) at fixed 3-monthly intervals over 15 months (subject retention 88%) with an
additional 25(OH)D assessment in spring 2008. Bone mineral density (BMD) at the lumbar spine (LS) and dual hip was
measured in autumn 2006 and spring 2007 (Lunar I-DXA). Deficiency prevalence (25(OH)D,25 nmol/L) was reduced in
women who went on holiday to sunny destinations 3 months prior to their visit, compared to women who did not go on
holidays [5.4% vs. 24.6% in Spring (p,0.001) and 3.8% vs. 25.6% in Winter (p = 0.001), respectively]. Similarly deficiency was
lower amongst those who took CLO supplements compared to women that did not consume these supplements [2.0% vs.
23.7% in Spring (p = 0.001) and 4.5% vs. 24.8% in winter (p = 0.005), respectively]. There was no seasonal variation in CTX;
25(OH)D predicted a small proportion (1.8% variation) of LS BMD in spring 2007 [unstandardized b (SE): 0.039 (0.016),
p = 0.017]. Seasonal variation of 25(OH)D had little effect on BMD and no effect on CTX. It appears that small increments in
vitamin D (e.g. those that can be achieved by cod liver oil supplements of 5 mg/day) are sufficient to ensure that 25(OH)D is
above 25 nmol/L for most people throughout the year. Similarly, holidays in sunny destinations show benefit.
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Introduction
Vitamin D has been linked with many health outcomes,
including multiple sclerosis [1], cardiovascular disease [2], cancer
[3] and all cause mortality [4]. The deficiency cut-off for vitamin
D status [,25 nmol/L for 25-hydroxyvitamin D (25(OH)D)] was
recommended with regard to preventing rickets (in children) and
osteomalacia (in adults) [5]. However, the quantity required for
optimum health overall, is currently hotly debated with many
researchers and clinicians advocating higher intakes and a higher
cut off of 25(OH)D (ranging from 50 to over 75 nmol/L) to define
deficiency and insufficiency [6–7].
Healthy adults obtain most of their vitamin D through exposure
of skin to sunlight [5] with natural dietary sources being limited
[8]. Hence it might be expected that seasonality [9], latitude [10]
and lifestyle would be important in vitamin D status. In addition,
sunlight exposure, and thus vitamin D synthesis, is thought to be
affected by Western lifestyles, which increasingly involve working
indoors during daylight hours as well as residence in northern
latitudes with cloudy climates [11]. As such, Scotland (higher
latitude) has a higher prevalence of levels below 40 nmol/L of
25(OH)D compared to the rest of the UK [9,12].
The aim of this study was to test the relationship between
vitamin D status, assessed longitudinally, and markers of bone
turnover and bone mineral density (BMD) in postmenopausal
women from Aberdeen North East Scotland (57u latitude). The
individual contributions on vitamin D status of a) diet (assessed by
the ‘gold’ standard method of 7 day food diary [13]) including
supplements that contain vitamin D such as cod liver oil and b)
sunlight exposure (objectively measured by polysulphone badges)
as well as holidays abroad in sunny destinations, were evaluated
according to season.
Materials and Methods
Study Participants
Subjects were postmenopausal Caucasian women recruited
from a cohort of well characterised women from the Aberdeen
Prospective Osteoporosis Screening Study (APOSS) [14]. The
study design has been described elsewhere [12,15]. In brief, 365
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women took part in the study; a flow diagram of the study
participants is shown in Figure 1. Women attended for 5 visits at
3 month intervals with the baseline visit being Spring 2006;
25(OH)D was also measured in Spring 2008.
Exclusion criteria included any disease or medication that could
potentially affect vitamin D status. Forty two women were
excluded due to abnormal routine biochemistry results obtained
at their first visit (elevated liver and thyroid function tests). Women
who were on vitamin D and calcium supplements were also
excluded. However, we allowed women into the study if they were
taking mixed multivitamins and minerals supplements and also
a proportion of women (up to 20%) who were taking cod liver oil
(CLO) supplements on a regular basis.
The women were weighed with a set of balance scales (Champ
II Base, Ohaus, Canada) calibrated to 0.5 kg, while wearing light
clothing and no shoes. Height was measured with a stadiometer
(Holtain, Ltd, Crymych, United Kingdom). Socio-economic status
was assessed by national deprivation scoring, based on residential
postal codes, from 1 (least deprived) to 7 (most deprived) [14].
Ethics Statement
Written informed consent was obtained for all the women and
the study was approved by the North of Scotland Ethics
Committee (REC reference number: 05/S0802/149). The study
was registered as the Aberdeen Nutrition Sunlight and Vitamin D
(ANSAViD) study at controlled-trials.com (ISRCTN96210443).
Diet, Sunlight and Physical Activity Assessment
Nutrient intakes were assessed at baseline (Spring 2006) by
a validated food frequency questionnaire (FFQ) [16]. For the
remaining visits (3 mo, 6 mo, 9 mo and 12 mo) diet was assessed
using the EPIC 7 day estimated food diary [17] and analysed using
‘Windiets’ (Robert Gordon University, Aberdeen, UK). The FFQ
gives higher estimates of intakes compared to food diaries [18].
There was no dietary intake assessment at year 2.Vitamin D intake
from supplements and cod liver oil was calculated from the
frequency of use and amount of vitamin D present in the brand
used as indicated by the manufacturers’ product label. Habitual
physical activity (PA) assessment was carried out using the
Aberdeen bone specific physical activity questionnaire (bsPAQ)
[19].
UV exposure was measured using two ultraviolet sensitive
polysulphone film badges worn at the lapel for 7 days at each visit.
The calculation of the standard erythemal dose (SED), which is
a measure of the erythemal effectiveness of a UV exposure [20],
has been described elsewhere [15]. The amount of body surface
area (BSA) exposed was obtained from sunlight exposure diaries
that were completed daily for the duration of the study [12]. At
each visit, details regarding holidays taken abroad during the
preceding 3 months and use of sun-protection cream, were
obtained. Women were asked at each visit whether they had been
on holiday ‘to a sunny destination in the past 3 months’. If the
answer was yes we asked them ‘where’ and ‘for how long’. Women
were similarly asked at each study visit whether they normally
Figure 1. Study Flow Diagram. (APOSS: Aberdeen Prospective Osteoporosis Study, OP: Osteoporosis, BL: Baseline visit).
doi:10.1371/journal.pone.0053381.g001
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wore sun protection cream and if their answer was positive what
factor was the sun cream. They were also asked about the use of
make-up that had UV protection.
Biochemical Markers and Bone Mineral Density
At each visit (including the year 2 visit), fasted serum 25(OH)D
was assessed by IDS enzyme immunoassay (Boldon, UK). The
assay had an intra-assay CV of ,16% across the working range of
6.8–380 nmol/L as defined using duplicates, calculating the CVs
for all measurements and producing a precision profile. The inter-
assay CV was 15.3% at 9.2 nmol/L, 7.1% at 51.5 nmol/L and
13.4% at 200.0 nmol/L. Women who had 25(OH)D below
25 nmol/L were considered to be deficient [5].
Fasted serum parathyroid hormone (PTH) was measured by
Roche EIA on the E module; the intra-assay CV was ,6%
(precision profile) across the range 1–70 pmol/L. The inter-assay
CV was 5.8% at 2.5 pmol/L, 4.9% at 7.3 pmol/L and 3.4% at
24.3 pmol/L. Fasted serum beta C-telopeptide (CTX) was
measured by an Enzyme Chemiluminescent Immuno-Assay
(ECLIA) supplied by Roche products Ltd (Penzberg, GmbH).
The inter-assay and intra-assay CVs were less than 4% (precision
profiles) across the range 0.01–2.0 mg/L. The inter-assay CV was
3.9% at 0.05 mg/L, 3.0% at 0.32 mg/L and 0.9% at 0.76 mg/L.
Beta C-telopeptide and PTH were not measured at the year 2
visits. All samples, for each subject, were stored together and
analyzed as a single batch.
Bone mineral density (BMD) was measured at the spine (LS)
and dual hips at the autumn (2006) visit and 6 months later in
spring (2007) by the same radiographer using a Lunar I-DXA
scanner (GE Medical Systems Inc. Madison WI). Total (dual) hip
BMD was used for subsequent analysis as the average of left and
right hip BMD values. Daily phantom measurements were
performed. In-house precision was obtained using 60 volunteers,
showing an in vivo coefficient of variation of 0.56% at the lumbar
spine and ,0.75% at the dual hip. Percentage bone change was
calculated as [(BMD spring – BMD autumn)/BMD autumn]* 100
at the lumbar spine and total hip sites.
A list of the different measurements taken at the different time
points during the study can be seen in Table 1.
Statistical Analysis
For the investigation of seasonal variation, the differences in
mean 25(OH)D, CTX and PTH between the different seasons
were tested by General Linear Model repeated measures analysis.
Statistical analysis was performed using SPSS version 19. All non-
normally distributed data were log-transformed before analysis.
One way ANOVA (with Scheffe post hoc analysis) was used to
investigate the effect of time gap between blood sampling and last
day on holidays abroad at each visit.
Mixed model analysis to include all seasons (summer 2006 to
spring 2007, inclusive), was performed in SAS (SAS 9.1.3, SAS
Institute Inc., Cary, NC, USA) using an unstructured covariance
structure. Baseline covariates tested included age, weight, height,
social deprivation category, sunscreen use, and years since
menopause. Only the significant baseline covariates were used as
covariates in subsequent models, with repeated measures of
sunlight exposure (SED as estimated with by dosimeter badges),
recent holiday abroad (yes/no), body surface area exposed and
total dietary intake of vitamin D.
Linear regression was used to estimate the percentage of
variance of LS and hip BMD attributed to 25(OH)D adjusted for
confounders (body weight, height, smoking, social deprivation
category, dietary calcium, alcohol intake, and physical activity),
and to determine whether summer-winter changes in 25(OH)D,
PTH and CTX or wintertime values of these variables (when
25(OH)D is lowest) could predict % BMD change.
Results
A total of 365 women attended the baseline visit, with good
retention for the 3-monthly visits ending in spring 2007 (88%
attendance) and 70% returning a year later in spring 2008. The
baseline characteristics are given in Table 2. The women that
took part in our study had similar baseline characteristics (age,
height, weight, BMI, smoking habits, and socioeconomic status)
Table 1. Parameters measured at each visit throughout the study period.
Parameter measured Spring2006 Summer 2006 Autumn 2006 Winter 2006/07 Spring 2007 Spring 2008
25(OH)D 3 3 3 3 3 3
PTH 3 3 3 3 3 3
CTX 3 3 3 3 3
DXA 3 3
Diet FFQ 7-day diary 7-day diary 7-day diary 7-day diary
Dietary supplement use 3 3 3 3 3
Sunlight (UV badges) 3 3 3 3 3
BSA (Sunlight diaries ) 3 3 3 3 3
Physical activity (bsPAQ) 3 3 3 3 3
Subjects’ characteristics 3
Questions about holidays in sunny
destinations and sun protection
cream use
3 3 3 3 3
Questions about changes in medication
and wellbeing since last visit
3 3 3 3 3
25(OH)D: 25 hydroxy vitamin D, PTH: parathyroid hormone, CTX: beta C-telopeptide, FFQ: Food frequency questionnaire, DXA: Dual X-ray absorptiometry, BSA: Body
surface area, bsPAQ: Bone specific physical activity questionnaire.
doi:10.1371/journal.pone.0053381.t001
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with the rest of the APOSS population (data not shown). One
subject was suspected of suffering from primary hyperparathy-
roidism and was excluded from further analysis.
Seasonal Variation of Biochemical Markers
There was a significant seasonal variation in serum 25(OH)D,
with a zenith in the summer and a nadir in spring and winter
(p,0.001) (Table 3). The percentage of population at different
25(OH)D cut off points has been reported elsewhere [21].
Periodicity in serum PTH peaked in the spring 2007 (p = 0.003),
while there were no differences in CTX according to season
(Table 3). Table 4 shows the relationships between different
markers of bone health at baseline. There was an inverse
relationship between PTH and 25(OH)D (p,0.01) which was
present at all visits (full data not shown). There was no association
between levels of 25(OH)D and CTX either at baseline (Table 4)
or at any subsequent visit (full data not shown).
Effect of Holidays and Cod Liver Use on 25(OH)D
Self-reported information on holidays taken in the sun (3
months prior to each visit) showed a total of 195 (62%) participants
reporting taking at least one holiday in the sun during the study
period, with 100 (51%) of these taking multiple holidays. Most
holidays were taken in summer or autumn, with a median
duration of 14 days (Table 5). The time interval between the date
of blood sampling and the last day of the reported holiday abroad,
before the sampling took place, ranged from 28d624 (SD) in
autumn 2006 to 47d629 (spring 2007). Mean 25(OH)D did not
differ between women whose blood samples were obtained less
than 7 days after the end of their holidays abroad compared to 7–
14 days, 14–30 and over 30 days afterwards (data not shown).
Although underlying seasonal trends were similar (Figure 2),
the effect of holidays in sunny destinations during the 3 month
period prior to blood samples being taken resulted in higher mean
25(OH)D. None of the women that reported going on holidays
abroad had 25(OH)D,25 nmol/L in the summer and ,7% were
below this cut off point of during the rest of the year (compared to
Table 2. Subject characteristics at baseline visit.
Subject characteristics n Mean 6 SD Min-max
Age (y) 364 62.061.4 59.1–65.0
Weight (kg) 352 71.7612.9 41.0–122.0
Height (cm) 352 160.665.7 146.0–188.5
Metabolic component of PA (MET/h.wk) 349 71.5666.7 11.5–194.2
Mechanical component of PA (peak scores) 349 4.561.6 0.0–10.0
Dietary calcium intake (mg/d)1 351 10406314 243–2359
Diet and supplement calcium (mg/d)1 351 10426315 243–2359
Dietary vitamin D (mg/d)1 351 4.362.5 0.5–24.4
Dietary vitamin D including supplements (mg/d)1 351 5.263.3 0.5–24.4
Energy intake (MJ/d)1 351 7.662.1 3.0–16.8
25 hydroxy vitamin D (nmol/L) 355 39.5618.8 11.4–145.4
Parathyroid hormone (pmol/L) 355 4.961.5 1.9–11.4
Beta C-telopeptide (mg/L) 355 0.3860.17 0.05–1.17
Socio-economic status2 (% in categories 1 to 6) 359 24, 47, 8, 11, 7, 3
1assessed by FFQ.
2assessed by national deprivation scoring 1 (least deprived) to 6 (most deprived).
doi:10.1371/journal.pone.0053381.t002
Table 3. Seasonality of serum 25(OH)D, PTH and CTX.
N 25(OH)D* % population PTH** CTX
N 25(OH)D* % population PTH**
Spring 2006(Mar–May) 355 39.4 (618.8) 21.0 5.04 (61.59) 0.385 (60.167)
Summer 2006(June–Aug) 335 55.7 (620.6) 2.7 4.92 (61.67) 0.382 (60.163)
Autumn 2006(Sep–Nov) 329 50.6 (621.6) 7.3 5.00 (61.84) 0.379 (60.161)
Winter 2006/07(Dec–Feb) 312 40.0 (619.3) 22.0 5.10 (61.68) 0.379 (60.162)
Spring 2007(Mar–May) 310 40.5 (619.5) 20.5 5.14 (61.93) 0.376 (60.155)
Spring 2008(Mar–May) 256 39.7 (619.4) 24.8
25(OH)D, 25-hydroxyvitamin D; PTH, Parathyroid hormone; CTX, beta C-telopeptide.
*Repeated measures ANOVA (Pillai’s Trace p,0.001) (variable log transformed if required).
**Repeated measures ANOVA (Pillai’s Trace p = 0.003) (variable log transformed if required).
Both p values remained significant after adjusting for multiple testing.
doi:10.1371/journal.pone.0053381.t003
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women who reported absence of holidays in sunny destinations)
(Table 6). There were no differences in baseline characteristics
(age, body weight, BMI, SED or multivitamin use) between the
women who holidayed abroad and those who did not (data not
shown). The low levels of deficiency (25(OH)D ,25 nmol/L) that
were observed in the women who went on holidays in the summer
2006 were preserved 3 months after the holiday occurred (3.2% vs.
10.8% for women who did not go on holidays, p = 0.046) but not 6
months after the initial holiday (when deficiency levels were at
29.5% vs. 30.9%, respectively). Similar results were observed for
the women who chose to go on holiday in the autumn (the second
most popular season to go on holidays in our population–
Table 5). Deficiency 3 months later (in winter 2006/07) was still
lower between those women who had been on holidays in a sunny
destination in autumn (14.5%) compared to women who did not
(30.6%, p= 0.005).
Women who reported consuming CLO supplements at the
baseline visit [N= 50 (spring 2006), 47 (summer 2006),46 (autumn
2006), 44 (winter 2006/07) and 37 (spring 2007)] had a higher
mean 25(OH)D compared to those who did not use these
supplements with the underlying seasonal trends remaining similar
(Figure 3).
The mean total vitamin D intake (mg/d 6 SD) of the women
that took CLO supplements was 9.263.0 in spring 2006, 8.863.4
in summer 2006, 8.262.8 in autumn 2006, 8.062.5 in winter
2006/07, and 8.363.3 in spring 2007. The corresponding total
vitamin D intakes for the women who did not take CLO
supplements at each of the 5 visits were 4.562.6, 3.062.5,
2.862.2, 3.162.4, and 3.164.9 mg/d (mg/d 6 SD) (p,0.001 for
all differences). Intakes of vitamin D were higher for spring 2006
compared to other visits as this was assessed by FFQ instead of
food diary (p,0.001 for CLO and for non-supplement users).
None of the women that took CLO were deficient (i.e.
25(OH)D,25 nmol/L) in the summer/autumn, and 4.5% were
below the deficiency cut off point in winter/spring 2007 (Table 6).
Again, there were no differences in baseline characteristics (age,
body weight, BMI, SED or multivitamin use) between the group
that took CLO supplements and the group that did not (data not
shown).
Effects of 25(OH)D Periodicity on BMD
There was no relationship between 25(OH)D and any of the
BMD measurements (Table 4). BMD was lower by 0.7% in
spring 2007 compared to the autumn 2006 at both total hip and
spine sites (p,0.001) but 25(OH)D only explained 1.8% of the
Table 4. Associations between markers of bone health at baseline (Spearman correlations).
BASELINE correlations 25(OH)D PTH CTX
Mean total hip BMD
- Autumn
Lumbar spine BMD -
Autumn
Mean total hip BMD
- Spring
R n (nmol/L) (pmol/L) (mg/L) (g/cm2) (g/cm2) (g/cm2)
PTH (pmol/L) 20.255*
n= 357
CTX (mg/L) 0.014 20.016
n= 357 n = 357
Mean total hip BMD (g/cm2) - Autumn 20.042 0.084 20.281*
n= 334 n = 334 n= 334
Lumbar spine BMD (g/cm2) - Autumn 20.062 0.071 20.235* 0.612*
n= 334 n = 334 n= 334 n = 334
Mean total hip BMD (g/cm2) - Spring 20.044 0.070 20.285* 0.993* 0.614*
n= 323 n = 323 n= 323 n = 321 n= 321
Lumbar spine BMD (g/cm2) - Spring 20.007 0.068 20.262* 0.625* 0.972* 0.634*
n= 329 n = 325 n= 325 n = 323 n= 323 n = 322
25(OH)D, 25-hydroxyvitamin D; PTH, parathyroid hormone; CTX, plasma beta C-terminal telopeptide; BMD, bone mineral density;
*P,0.01 (variable log transformed if required).
doi:10.1371/journal.pone.0053381.t004
Table 5. Prevalence and duration of holidays abroad (in the 3 months prior to each visit) according to season.
No holidays in the previous 3
months
On holidays in the previous 3
months Median holiday duration
n (%) n (%) days (IQR)
Spring 2006(Mar–May) 289 (80) 74 (20) 14 (7–14)
Summer 2006(June–Aug) 234 (69) 104 (31) 14 (7–14)
Autumn 2006(Sep–Nov) 221 (70) 96 (30) 14 (7–14)
Winter 2006/07(Dec–Feb) 262 (83) 52 (17) 11 (7–14)
Spring 2007(Mar–May) 251 (81) 58 (19) 14 (7–21)
doi:10.1371/journal.pone.0053381.t005
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lumbar spine variation [unstandardized b (SE): 0.039 (0.016),
p = 0.017 in the Spring 2007 measurement]. Summer-winter
change in 25(OH)D, CTX and PTH were not significant
predictors of % change BMD at any site and neither were winter
values of 25(OH)D (when vitamin D status is at its lowest) or PTH.
There was an inverse association between the CTX (bone
resorption marker) and both hip and lumbar spine BMD
measurements. CTX was the only variable that predicted %
change BMD during winter [(2.5% of the LS variation (un-
standardized b (SE): 22.692 (0.952)] and 3.0% of the total hip site
variation [(unstandardized b (SE): 21.414 (0.460) (full data not
shown)].
Figure 2. Differences in 25(OH)D between women who have had holidays abroad the preceding 3 mo from their study visits [N=74
(spring 2006), 104 (summer 2006), 96 (autumn 2006), 52 (winter 2006/07), 58 (spring 2007), 40 (spring 2008] and those who did not
(N=289, 234, 231, 262, 251, 218, respectively). (all differences where statistically significant at p,0.001.) 25-hydroxyvitamin D (25(OH)D) (bars
represent mean 6 SEM) according to season/visit.
doi:10.1371/journal.pone.0053381.g002
Table 6. Percentage of population deficient (25(OH)D ,25 nmol/L) according to holidays in sunny destinations and cod liver oil
use.
Spring 2006 Summer 2006 Autumn 2006 Winter 2006/07 Spring 2007
On holidays in the previous 3 months 5.4 0.0 4.2 3.8 6.9
No holidays in the previous 3 months 24.6 3.8 8.7 25.6 23.9
P* value ,0.001 0.062 0.236 0.001 0.007
Cod liver oil use 2.0 0.0 0.0 4.5 4.5
No cod liver oil use 23.7 3.1 8.4 24.8 23.1
P* value 0.001 0.691 0.058 0.005 0.009
*chi squared test (continuity correction or Fishers exact test, where appropriate).
doi:10.1371/journal.pone.0053381.t006
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Mixed Model Analysis
The mixed model approach with repeated measures, showed
that season (summer, autumn compared to spring), recent holiday
abroad (in the last 3 months) weight and BSA were significant
predictors of 25(OH)D concentration (Table 7). Sunlight
exposure, as assessed by dosimeter badges, was not a significant
predictor but was included in the model, as it a known contributor
of vitamin D status. The final equation including dietary vitamin
D, which was significant at the 1% level was as follows: Ln
25(OH)D=3.710+0.296 (summer) +0.328 (autumn) +0.031 (win-
ter) –0.003 (weight in kg) +0.083 (sunblock use: yes) +0.127 (recent
holiday abroad: yes) +0.002 (sunlight exposure in SED) +0.003
(BSA in %) +0.007(dietary vitamin D in mg/day). Thus for
example, the model predicted that a postmenopausal woman
living at 57uN, who weighed 70 kg, did not use sun cream, had not
been abroad in the previous 3 months, having an average sun
exposure and consuming 2.5 mg/day of dietary vitamin D, would
have circulating 25(OH)D of 49.3 nmol/L in the summer. The
same woman in the winter would have an estimated 25(OH)D of
35.1 nmol/L.
Similarly, the equation from the mixed model with repeated
measures for PTH was : Ln PTH =1.544+0.006 (weight in kg) –
0.108 Ln 25(OH)D. Only body weight and 25(OH)D were
significant predictors of PTH.
Discussion
This longitudinal study at Northerly latitude showed that
despite fluctuation in vitamin D status (with a peak in summer and
a nadir in winter/spring), bone resorption remained unchanged
throughout the 15-month observation period (adjustment for
multiple testing did not change these relationships). BMD was
found to decrease by a small increment (,1%) between autumn
2006 and spring 2007. Overall serum 25(OH)D was not predictive
of BMD except for a very small proportion of the variation in
lumbar spine BMD in spring. A possible explanation for this might
be that lifetime 25(OH)D may be more important for bone health
than recent 25(OH)D measurements. In addition, our population
had overall low vitamin D status and it has been suggested that
levels .75 nmol/L are needed for improvements in bone health
[22].
Others have reported cross-sectional data that seasonal changes
in bone resorption markers are linked to seasonal changes in
vitamin D status for older women in south-eastern Australia (38–
Figure 3. Differences in 25(OH)D between women that reported taking cod liver oil supplements [N=50 (spring 2006), 47 (summer
2006), 46 (winter 2006/07), 44 (spring 2007), 37 (spring 2008] vs. those who did not (n=303, 289, 285, 269, 268, 221, respectively).
(all differences where statistically significant at p,0.003 except for Summer for which p,0.01.) 25-hydroxyvitamin D (25(OH)D) (bars represent mean
6 SEM) according to season/visit.
doi:10.1371/journal.pone.0053381.g003
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39uS) [23], Cork, Ireland (52uN) [24] and Nebraska, US (41uN)
[25]. We reported similar associations in our cross-sectional data
[26], but this was not confirmed in the current longitudinal study
where the same subjects had five consecutive serum 25(OH)D and
CTX measurements at fixed 3 monthly periods. Potential
explanations for this include differences in age and menopausal
status (postmenopausal versus within 5 years of the menopause
and 7 years younger), the bone resorption marker measured
(serum CTX versus urinary free deoxypyrinoline), and sample size
(365 versus 3113). However, our study sample size was adequate to
determine an 8% summer-winter difference in CTX at the 89%
level (p = 0.05). Alternatively the difference in study design suggests
that the within-individual bone turnover variation is conserved
relative to between-individual variation [15].
The 25(OH)D measures during the three spring periods were
almost identical despite different weather (sunshine hours) in the
preceding summer and a particular poor summer in 2007 [27].To
our knowledge this is the first longitudinal study to report measures
of 25(OH)D consecutively for 3 years (2006–08) during the Spring
seasons, when the vitamin D status is at its lowest in the UK. This
finding suggests that 25(OH)D is being conserved either by
topping up from vitamin D stores in the body, or may be protected
for example through vitamin D binding protein [28]. Vitamin D
binding protein may behave as a serum carrier and reservoir
believed to prolong the half life of circulating vitamin D and
regulating its bio-availability to target tissues [29].
There was an inverse periodicity of serum PTH with 25(OH) D,
significant for each season except summer, although the 25(OH)D
fluctuation was not as marked in our population as reported in
other studies (e.g. [23], [24], [25], [30]) and few subjects had
25(OH)D concentrations .75 nmol/L. The Northerly latitude
and poor weather may explain the smaller increase of 25(OH)D
during the summer, although it is then surprising that 25(OH)D
did not fall to even lower concentrations in the winter. The smaller
seasonal fluctuation in 25(OH)D may reduce the PTH fluctuation
which in turn further reduces the CTX fluctuations. However, the
concentrations of circulating PTH observed in our population
were similar to others [30] (although caution should be advised
when comparing studies because of differences in the analytical
methods, and study designs i.e. cross-sectional vs. longitudinal
data).
Ultraviolet radiation exposure from sunny holidays outside the
UK appeared to alleviate the risk of deficiency (25(OH)D,25 n-
mol/L) for the majority of the women and this effect was preserved
3 months after the holiday occurred. It is known that travelling
abroad to sunny resorts can completely change the UV dose
pattern of an individual. Danish indoor workers who went on
holiday for a median of 7 days received 26 SED compared with
a median of 3.1 SED for the entire winter [31]. In a laboratory
setting, 1.3 SED, 3 times a week for 6 weeks while wearing T-shirt
and shorts, increased mean 25(OH)D from 44 to 70 nmol/L [32].
Our volunteers only wore their dosimeter badges while in
Aberdeen, so we could not estimate the SED they received on
holiday but the higher concentrations of 25(OH)D, compared to
those who did not go on holidays abroad, show a marked effect on
vitamin D status. The inclusion of sun protection cream usage as
a positive predictor of 25(OH)D in the mixed model would appear
to be counter intuitive, since sun protection creams are supposed
to prevent UVB radiation reaching the skin. One explanation is
that these women do not use sun protection cream as thickly or as
often to exposed areas as would be recommended, so in fact they
receive sufficient UVB radiation to be able to synthesise vitamin
D.
Deficiency (25(OH)D,25 nmol/L) was also alleviated [0%
(summer/autumn) and 4.5% (winter/spring)] for the majority of
women who took dietary supplements containing vitamin D (cod
liver oil) compared to women that only received vitamin D via
food sources. Few foods naturally contain vitamin D and the
addition of vitamin D from supplements (5mg or 200 IU) more
than doubles overall vitamin D intakes. The effect of cod liver oil
supplements in raising 25(OH)D was also observed in the UK
National Diet and Nutrition Survey (NDNS) for women aged 50–
64 years. They reported an association between total dietary
vitamin D (including cod liver oil supplements) with 25(OH)D
(r = 0.33, p,0.01) but no association between 25(OH)D and food
only derived vitamin D [33]. We reported similar cross-sectional
associations in the APOSS population for total dietary vitamin D
intake and 25(OH) D [26]. The current study suggests that oral
vitamin D intake has a significant effect in alleviating vitamin D
deficiency (25(OH)D),25 nmol/L) only when dietary supple-
ments (cod liver oil) are included.
The strength of our data is that vitamin D was measured
longitudinally in a cohort of older free living women at northerly
latitude in the UK. The study was carefully done, with women
attending visits at strictly controlled time intervals and included
gold-standard measures of sunlight exposure and diet.
The main limitations are that our findings are observational,
and not causative. The study was carried out in a small well-
defined cohort of older postmenopausal Caucasian women and
cannot be extrapolated to the general population. In addition, we
did not measure health outcomes other than bone health. Very
few individuals in our population had 25(OH)D above 75 nmol/L
and as this is considered by some experts to be optimal for bone
health this might pose as a limitation. The information regarding
Table 7. Mixed model regression equation: all women final
model.
All women: 334 subjects, 1171 observations used
Independent variable1 Beta SEM P
Dependent variable 25(OH)D2 Mixed Model
Constant +3.710 0.105 ,0.001
Season: ,0.001
Summer +0.300 0.022
Autumn +0.233 0.019
Winter +0.031 0.016
Spring 2007 reference 0
Weight (kg) 20.003 0.001 0.028
Sun block use (yes) +0.084 0.016 ,0.001
Recent holiday abroad (yes) +0.127 0.015 ,0.001
Sunlight exposure (SED) +0.002 0.002 0.203
Body surface area (%) +0.003 0.001 0.040
Dietary vitamin D3 (mg/day) +0.007 0.003 0.009
SED: Standard erythemal dose.
1From sunlight vitamin D (as assessed from polysulphone badges), total dietary
vitamin D intake (by food diary only), recent holiday abroad, body weight, body
surface area exposed to sunlight and sunblock use. Physical activity was not
found to be significant predictor and not included in the final model.
225-hydroxyvitamin D (25(OH)D) was log transformed to obtain normal
distribution.
3Including supplements (mainly cod liver oil which adds 5 mg vitamin D a day).
All p values maintained significance after adjustment for multiple testing,
except from body surface, that was borderline significant even before
adjustment (p = 0.04), and body weight.
doi:10.1371/journal.pone.0053381.t007
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the holidays to sunny destination was self reported; we did not
independently confirm the weather conditions to these holiday
destinations and the dosimeter UV badges were not used abroad.
As such this study has limited power to detect the exact necessary
time to a sunny estimation or latitude required to alleviate
25(OH)D deficiency. It is possible that the benefits of CLO and
holidays abroad are confounders as they may be confined to
a healthy population (although women who went on holidays
abroad did not necessarily consume CLO and vice versa and the
baseline characteristics between the groups (those who went on
holidays in sunny destinations or took CLO vs. those who did not)
did not differ. The study was not powered to examine any
potential interactive effects of holidays abroad and cod liver oil
usage on vitamin D status. In addition, there may be long-term
effects on bone (more than the 15 month duration of this study)
that this investigation was not designed to measure (e.g. fracture
rates).
Conclusion
In conclusion, for a substantial number of women living at
northerly latitudes, 25(OH)D falls below 25 nmol/L for part of the
year but this did not appear to influence bone resorption and had
only a very small effect on BMD which might have limited clinical
significance. Whether this finding is important for long-term bone
health and other related health outcomes (e.g. CVD, cancer etc)
requires further interventional studies. It appears that for our
postmenopausal Caucasian population small increments, as would
be given in cod liver oil capsules (200 IU daily) or modest dietary
supplements, are sufficient to ensure that 25(OH)D remains above
25 nmol/L for most people throughout the year. Similarly,
holidays in the sun also show benefit. More may be required to
maintain higher circulating 25(OH)D concentrations.
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